Clinical Trial Update: Naltrexone and Adrenergic Agents to Reduce Heroin Use in Heroin Addicts [Phase 2]

View source ↗

Summary

A Phase 2 clinical trial update evaluating naltrexone combined with adrenergic agents to reduce heroin use in individuals with heroin dependence has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Heroin Dependence

Drugs mentioned

• Adrenergic agents (adrenergic agents)
• Naltrexone (Naltrexone)

Snippet

Sponsor: Baylor College of Medicine | Conditions: Heroin Dependence | Phase 2 | Status: COMPLETED